Barinthus Biotherapeutics (BRNS) Goodwill (2021 - 2024)

Barinthus Biotherapeutics has reported Goodwill for 4 years, with the latest figure at $12.2 million in Q3 2024.

• For the quarter ending Q3 2024, Goodwill changed 0.0% year-over-year to $12.2 million; the trailing twelve-month figure through Sep 2024 stood at $12.2 million (changed 0.0% YoY), and the FY2023 full-year result was $12.2 million, changed 0.07% from the prior year.
• Goodwill for Q3 2024 stood at $12.2 million, roughly flat from $12.2 million in the prior quarter.
• The five-year high for Goodwill was $12.6 million in Q4 2021, with the low at $12.2 million in Q4 2023.
• Historically, Goodwill has averaged $12.3 million across 4 years, with a median of $12.2 million in 2022.
• Annual changes were most pronounced in 2022 — Goodwill slipped 3.33% — and 2024, when it changed 0.0%.
• Barinthus Biotherapeutics' Goodwill stood at $12.6 million in 2021, then fell by 3.33% to $12.2 million in 2022, then fell by 0.07% to $12.2 million in 2023, then gained by 0.07% to $12.2 million in 2024.
• The last three Goodwill figures came in at $12.2 million (Q3 2024), $12.2 million (Q2 2024), and $12.2 million (Q1 2024), per Business Quant data.